Description: Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and fine chemicals in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was founded in 2007 and is based in Hyderabad, India.
Home Page: vineetlabs.co.in
5-5-160, Malleswari Nilayam
Hyderabad,
500074
India
Phone:
91 40 2412 8833
Officers
| Name | Title |
|---|---|
| Mr. Gaddam Venkata Ramana | Founder, MD & Director |
| Mr. Satyanarayana Raju Bhupathiraju | CFO & Whole-time Director |
| Mr. Kandula Murali Mohan | General Manager of Operations |
| Mr. Rameshkumar Bandari | Company Secretary & Compliance Officer |
| M. Venkata Ramana Ravi | Sr. Manager of Marketing |
| Mr. Pavani Srinivasa Rao | Manager of HR |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| GIC Sector: | Materials |
|---|---|
| GIC Group: | Materials |
| GIC Industry: | Chemicals |
| GIC Sub-Industry: | Commodity Chemicals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.6155 |
| Price-to-Sales TTM: | 0.3635 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 79 |